Kezar Life Sciences, Inc. (KZR) EBITDA Margin (2023)
Kezar Life Sciences (KZR) posted EBITDA Margin of 364.67% for Q3 2023.
Kezar Life Sciences, Inc. (KZR) EBITDA Margin (2023) Analysis & Trends
Kezar Life Sciences has reported EBITDA Margin for 1 years, with the latest figure at 364.67% in Q3 2023.
- Quarterly EBITDA Margin changed N/A year-over-year to 364.67% in Q3 2023, while the trailing twelve-month figure through Dec 2024 was 1294.36% (up 29741.0% YoY) and the FY2023 annual result came in at 1591.77%, changed N/A from the prior year.
- EBITDA Margin held at 364.67% in Q3 2023 per KZR's latest filing.
- Over five years, EBITDA Margin peaked at 364.67% in Q3 2023 and troughed at 364.67% in Q3 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -364.67% |